Connect with others who understand.

  •   Learn from expert-reviewed resources
  •   Real advice from people who’ve been there
  •   People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLeukemiaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

I'm currently on watch and wait and not taking any medications or receiving treatments, but I want to be prepared when the time comes.

November 5
 · 
Reactions
MyLeukemiaTeam

Planning ahead while on watch and wait is a really smart move! While specific Medicare plan comparisons aren't something that can be provided here, there are some great ways to get the guidance you need.

Here are some helpful steps to take:

- Talk to a financial counselor — Many cancer treatment centers have counselors who Show Full Answer

Planning ahead while on watch and wait is a really smart move! While specific Medicare plan comparisons aren't something that can be provided here, there are some great ways to get the guidance you need.

Here are some helpful steps to take:

- Talk to a financial counselor — Many cancer treatment centers have counselors who specialize in helping patients navigate insurance and find assistance programs
- Contact the Leukemia & Lymphoma Society — They have resources specifically to help with treatment costs and prescription coverage
- Reach out to the American Cancer Society — They can also help identify programs to cover gaps in coverage
- Ask your oncologist's billing department — They often know which plans work best for the medications commonly used to treat CLL When the time comes, CLL treatment can involve several medications, some of which can be costly. Many pharmaceutical companies offer assistance programs, copay support, or discount coupons for specific leukemia drugs.

It's worth knowing that common CLL treatments include targeted therapies like ibrutinib, acalabrutinib, and venetoclax — so researching coverage for these specifically may be a good starting point when comparing plans.

November 5

Related Questions

View All
A MyLeukemiaTeam Member asked a question 💭
Dallas, TX